Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 1
Submit an article Journal homepage
2,255
Views
4
CrossRef citations to date
0
Altmetric
Coronavirus – Research Paper

Effectiveness of CoronaVac in preventing COVID-19 in healthcare workers

Gulsum Iclal Bayhana Department of Pediatric Infectious Disease Ankara City Hospital, Children’s Hospital, Faculty of Medicine, Yildirim Beyazit University, Ankara, Turkey;b Department of Infectious Disease and Clinical Microbiology, Ankara City Hospital, Faculty of Medicine, Yildirim Beyazit University, Ankara, TurkeyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1423-4348View further author information
ORCID Icon &
Rahmet Gunerb Department of Infectious Disease and Clinical Microbiology, Ankara City Hospital, Faculty of Medicine, Yildirim Beyazit University, Ankara, TurkeyORCID Iconhttps://orcid.org/0000-0002-1029-1185View further author information
ORCID Icon
Article: 2020017 | Received 16 Sep 2021, Accepted 14 Dec 2021, Published online: 16 Feb 2022

References

  • WHO. [accessed 2021 Sept 16]. https://extranet.who.int/pqweb/sites/default/files/documents/Status%20of%20COVID-19%20Vaccines%20within%20WHO%20EUL-PQ%20evaluation%20process%20-%203%20June%202021r.pdf.
  • Tanriover MD, Doğanay HL, Akova M, Güner HR, Azap A, Akhan S, Köse Ş, Erdinç FŞ, Akalın EH, Tabak ÖF, et al. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey. Lancet. 2021;398:213–5. doi:10.1016/S0140-6736(21)01429-X.
  • Palacios R, Batista AP, Albuquerque CSN, Patiño EG, Santos JP, Conde MTRP, Piorelli RO, Júnior LCP, Raboni SM, Ramos F, et al. Efficacy and safety of a COVID-19 inactivated vaccine in healthcare professionals in Brazil: the PROFISCOV study. SSRN. published online 2021 Apr 14. doi:10.2139/ssrn.3822780. (preprint).
  • Souza WM, Amorim MR, Sesti-Costa R, Coimbra LD, Brunetti NS, Toledo-Teixeira DA, de Souza GF, Muraro SP, Parise PL, Barbosa PP, et al. Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study. Lancet Microbe. 2021 July 8;2:e527–e535. doi:10.1016/S2666-5247(21)00129-4.
  • Jara A, Undurraga EA, González C, Paredes F, Fontecilla T, Jara G, Pizarro A, Acevedo J, Leo K, Leon F, et al. Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile. N Engl J Med 285 . 2021 :875–884.
  • Duerr R, Dimartino D, Marier C, Zappile P, Wang G, Lighter J, Elbel B, Troxel AB, Heguy A. Dominance of alpha and Iota variants in SARS-CoV-2 vaccine breakthrough infections in New York City. J Clin Invest. 2021 Aug 10;131:152702. doi:10.1172/JCI152702.
  • Bergwerk M, Gonen T, Lustig Y, Amit S, Lipsitch M, Cohen C, Mandelboim M, Gal Levin E, Rubin C, Indenbaum V, et al. Covid-19 breakthrough infections in vaccinated health care workers. N Engl J Med. 2021 July 28;385:1474–84. doi:10.1056/NEJMoa2109072.
  • Hitchings MDT, Ranzani OT, Torres MSS, de Oliveira SB, Almiron M, Said R, Borg R, Schulz WL, de Oliveira RD, Da Silva PV, et al. Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 Gamma variant transmission in Manaus, Brazil: a test-negative case-control study. Lancet Reg Health Am. 2021 Sept;1:100025. doi:10.1016/j.lana.2021.100025.
  • [accessed 2021 Sept 16]. https://www.dw.com/tr/delta-varyant%C4%B1-t%C3%BCrkiyede-ne-kadar-yayg%C4%B1n/a-57984629.
  • [accessed 2021 Sept 16]. https://www.aa.com.tr/tr/koronavirus/koronavirus-bilim-kurulu-uyesi-korukluoglu-agustosta-vakalarin-yuzde-80i-delta-varyanti-olacak/2298422.
  • Luo CH, Morris CP, Sachithanandham J, Amadi A, Gaston D, Li M, Swanson NJ, Schwartz M, Klein EY, Pekosz A, et al. Infection with the SARS-CoV-2 delta variant is associated with higher infectious virus loads compared to the alpha variant in both unvaccinated and vaccinated individuals. medRxiv. 2021 Aug 20;8(15):21262077. doi:10.1101/2021.08.15.21262077. (Preprint).
  • Brown CM, Vostok J, Johnson H, Burns M, Gharpure R, Sami S, Sabo RT, Hall N, Foreman A, Schubert PL, et al. Outbreak of SARS-CoV-2 infections, including COVID-19 vaccine breakthrough infections, associated with large public gatherings - Barnstable County, Massachusetts, July 2021. MMWR Morb Mortal Wkly Rep. 2021 Aug 6;70(31):1059–62. doi:10.15585/mmwr.mm7031e2.
  • Vacharathit V, Aiewsakun P, Manopwisedjaroen S, Srisaowakarn C, Laopanupong T, Ludowyke N, Phuphuakrat A, Setthaudom C, Ekronarongchai S, Srichatrapimuk S, et al. CoronaVac induces lower neutralising activity against variants of concern than natural infection. Lancet Infect Dis. 2021 Aug 26;S1473-3099(21):00568–5.
  • Lumley SF, O’Donnell D, Stoesser NE, Matthews PC, Howarth A, Hatch SB, Marsden BD, Cox S, James T, Warren F, et al. Antibody status and incidence of SARS-CoV-2 infection in health care workers. N Engl J Med. 2021;384:533–40. doi:10.1056/NEJMoa2034545.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.